Evaluation of Rifaximin SSD for Delaying Encephalopathy Decompensation in Patients With Cirrhosis

NCT05297448 · clinicaltrials.gov ↗

PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

466

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatic Encephalopathy

Interventions

DRUG: Rifaximin SSD
DRUG: Placebo

Sponsor

Bausch Health Americas, Inc.